BRIEF published on 07/23/2026 at 09:05, 19 days 22 hours ago Aiforia Technologies Downgraded to 'Hold' Following Profit Warning NuWays AG Revenue Decline Profit Warning Aiforia Technologies Stock Downgrade
PRESS RELEASE published on 07/23/2026 at 09:00, 19 days 22 hours ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): HOLD Aiforia Technologies Oyj downgraded to HOLD after issuing H1 profit warning with revenues at €0.75m, order book at €3.5m, and mid-term targets for financial independence by 2027 Revenues HOLD Financial Independence Profit Warning Aiforia Technologies Oyj
BRIEF published on 06/29/2026 at 09:05, 1 month 12 days ago Aiforia Technologies Oyj Strengthens Financial Position with New Share Issue Revenue Growth Financial Strategy Share Issue Aiforia Technologies AI-Powered Pathology
PRESS RELEASE published on 06/29/2026 at 09:00, 1 month 12 days ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY Aiforia Technologies Oyj completes €6.4m share issue, raising sufficient liquidity. Placement de-risks investment case, sets stage for revenue ramp-up and clinical momentum acceleration Liquidity Investment Share Issue Aiforia Technologies Oyj Revenue Ramp-up
BRIEF published on 06/17/2026 at 09:05, 1 month 24 days ago Aiforia Technologies Secures Potential €20M EIB Venture Debt European Investment Bank Non-binding Agreement Aiforia Technologies Venture Debt Funding Outlook
PRESS RELEASE published on 06/17/2026 at 09:00, 1 month 24 days ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY Aiforia Technologies Oyj agrees on a non-binding indicative term sheet with the European Investment Bank (EIB) for a venture debt facility of up to € 20m, de-risking funding outlook and boosting investor confidence Investor Confidence European Investment Bank Aiforia Technologies Oyj Funding Outlook Venture Debt Facility
BRIEF published on 05/11/2026 at 09:05, 3 months ago NuWays AG Recommends Buy for Aiforia Technologies Oyj NuWays AG Oncology Diagnostics Aiforia Technologies AI Pathology Healthcare M&A
PRESS RELEASE published on 05/11/2026 at 09:00, 3 months ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY Update on Aiforia Technologies Oyj classification from NuWays AG including strong market catalyst and analysis on AI pathology in the clinical oncology diagnostics field NuWays AG Market Analysis Oncology Diagnostics Aiforia Technologies Oyj AI Pathology
BRIEF published on 04/17/2026 at 09:05, 3 months 24 days ago Aiforia Technologies Secures Exclusive AI Partnership in France AI Diagnostics Aiforia Technologies PROSTIA Project AP-HP Partnership French Healthcare
PRESS RELEASE published on 04/17/2026 at 09:00, 3 months 24 days ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY Aiforia Technologies Oyj selected as sole AI partner for PROSTIA project by Assistance Publique-Hôpitaux de Paris, expanding cancer diagnostics in France. Landmark deployment validates Aiforia's market leadership Cancer Diagnostics France AI Partner Aiforia Technologies Oyj PROSTIA Project
Published on 08/12/2026 at 00:00, 7 hours 21 minutes ago Organto Foods Reports Record Second Quarter 2026 Financial Results
Published on 08/11/2026 at 23:40, 7 hours 41 minutes ago RJK Explorations Ltd. Announces Private Placement for Gross Proceeds of up to $100,000
Published on 08/11/2026 at 23:15, 8 hours 6 minutes ago Fermi and Hillcore Energy Capital Announce 2.6 Gigawatt Power Strategic Alliance for Project Matador
Published on 08/11/2026 at 23:00, 8 hours 21 minutes ago Prospectiva Resources Ltd. Completes Qualifying Transaction
Published on 08/11/2026 at 22:55, 8 hours 26 minutes ago NV Gold Announces Non-Brokered Private Placement
Published on 08/12/2026 at 07:10, 11 minutes ago Deutsche Konsum Real Estate AG publishes quarterly statement for the first nine months of the 2025/2026 financial year
Published on 08/12/2026 at 07:00, 21 minutes ago MindMaze Therapeutics Appoints Prof. John W. Krakauer as Strategic Advisor
Published on 08/12/2026 at 07:00, 21 minutes ago SCHOTT Pharma with strong third quarter and on track for planned growth
Published on 08/12/2026 at 07:00, 21 minutes ago TUI delivered resilient Q3 underlying EBIT of €234.6m (at CC), demonstrating the strength of its business despite geopolitical headwinds and one-offs, FY26 guidance reaffirmed
Published on 08/12/2026 at 07:00, 21 minutes ago E.ON remains on track and continues to invest in the energy transition
Published on 08/10/2026 at 18:00, 1 day 13 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 11:53, 1 day 19 hours ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Published on 08/10/2026 at 11:36, 1 day 19 hours ago GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
Published on 08/10/2026 at 09:22, 1 day 21 hours ago Number of shares and voting rights - July 2026 (In French only)
